Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE)
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Sponsor: Henan Cancer Hospital